Skip to main content
OpenTrials
Completed

NCT Number: NCT06190587

Effect of Goji Berry Consumption on Biochemical Parameters

Goji Berry as a functional food have been shown to reduce risk of hyperlipidemia, type 2 diabetes, etc. However, human studies are limited in this area. In this study, it has been aimed to evaluate the effect of goji berry consumption on some biochemical parameters in healthy individuals.

Completed

Looking for future studies?

Notify Me

Key information

Age range

19 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Eastern Mediterranean University

Famagusta, Turkish Republic of Northern Cyprus, Cyprus

About this study

Healthy individuals have been divided into control and study groups. Individuals in both group have same characteristics such as age, gender, and body mass index (Control Group: 35 individuals - Study Group: 35 individuals). Both group were asked to maintain their normal diets. In addition, the study group consume 20 g of dried goji berry per day and did not consume any fruit with a similar antioxidant content during the 8 weeks study period. The control group was asked to exclude goji berry and similar fruits with high antioxidant content from their diet during the 8 weeks study period. The 20 g goji berry for per day was given weekly to each individual in a study group in transparent bags. At the beginning of the study and every 15 days, food consumption record for 3 consecutive days (2 weekdays and 1 weekend), a 3-day physical activity record, and anthropometric measurements (weight, height, waist and hip circumferences, body composition analysis) were taken. Blood parameters (total cholesterol, high density lipoprotein (HDL), low density lipoprotein (LDL), very low density lipoprotein (VLDL), triglyceride, glucose, insulin, homeostatic model assessment of insulin resistance (HOMA-IR), HbA1c) of individuals were taken at the beginning and the end of the study.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • BMI between 20-25 kg/m²
  • Female individuals are not in the period of lactation and menopause,
  • Absence of any chronic or acute disease diagnosed by a physician,
  • No allergies to Goji Berry
  • Not consuming goji berry and similar fruits regularly for the last 1 month.
  • Not being in the process of body weight loss
  • Not doing strenuous physical activity
  • Not taking any medication or antioxidant vitamin support
  • Not smoking
  • Not consuming alcohol (moderate alcohol consumption)

Exclusion criteria

Not meeting the criteria for inclusion in the study

Treatment and study plan

Goji Berry

Dietary Supplement

As a functional food goji berry contains 19 amino acids, 21 minerals, a wide range of carotenoids (β-Carotene, Neoxanthin, Cryptoxanthin, Zeaxanthin), polysaccharides, flavonoids, phytosterols, vitamin A, C and E.

Primary outcomes

  1. serum lipids

    Time frame: 8 weeks

    change in serum lipids level in interventional group.

  2. fasting glucose

    Time frame: 8 weeks

    change in fasting glucose levels in interventional group.

  3. serum insulin

    Time frame: 8 weeks

    change in serum insulin levels in interventional group.

Sponsors and collaborators

Lead sponsor

Eastern Mediterranean University

Other

Registry information

Official study title

The Evaluation of the Impact of Goji Berry Consumption Some Biochemical Parameters in Healthy Individuals

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Jan 5, 2024
Registry last updated
Jan 5, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.